IPO

A new plant-derived drug shows promise in preventing prostate cancer and improving cholesterol, but the company faces significant financial hurdles ahead.

The iconic brand is pivoting from its print legacy to a diversified lifestyle empire, and it has a new plan to convince investors it's the right move.

With promising new data for its cancer and obesity pipeline, Corbus Pharmaceuticals prepares for a crucial investor presentation at the Oppenheimer conference.

Gilat DataPath will supply advanced, combat-proven SATCOM terminals to a European MoD, marking a key expansion in the region's push for digital sovereignty.

Crypto giants BitGo and 21shares expand their global partnership, building regulated infrastructure to meet surging institutional demand for digital assets.

Vietnam's FPT earns its second recognition in a key Gartner Market Guide, validating its AI-driven strategy and deep expertise in a crowded M365 market.

Proem Acquisition Corp I launches a $130M IPO, led by tech IPO guru Imran Khan. But can it succeed in a revived, yet risk-laden, SPAC landscape?

With a strong cash position, Arcus Biosciences heads into a pivotal year as investors await critical data on its promising cancer and autoimmune pipeline.

Gloo's major sponsorship of NRB 2026 signals a new era of AI in faith, but raises critical questions about technology's role in modern spirituality.

Social Commerce Partners Corp. begins separate trading for its shares and warrants, a key step as it navigates a tough market to find a target in direct selling.

Following key FDA progress for its oral osteoporosis drug, Entera Bio's CEO and board members are buying up company stock, signaling deep confidence.

As a wave of old solar panels looms, Comstock Inc. is betting on a certified zero-landfill recycling facility. Can this green venture save its financials?

HeartCore Enterprises forecasts a dramatic swing to profitability in 2025 after divesting its software unit, betting its future on IPO consulting.

A new social commerce platform lets you earn company equity by shopping for Nike and Adidas. Can it change how we shop and keep our fitness goals?

Exodus reports a surge in users and swap volume for January, defying a market downturn while strategically increasing its Solana treasury holdings.

Following a volatile Nasdaq debut and soaring revenue, Virtuix brings its pricey Omni One VR treadmill to Europe, betting big on the 'gamified fitness' trend.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

As F1 enters a new era, Red Bull Ford Powertrains relies on Hexagon's sub-micron measurement tech to build its revolutionary 2026 engine from scratch.

A new study suggests couples who game together have higher satisfaction. But is it a real relationship boost or just clever marketing for Valentine's Day?

Frequency Holdings (OTC: FRQN) plants its flag at 14 Wall Street, a high-stakes play for 'optics and access' amid a volatile market position.